@article{0533ca1a682241dab232ed1c43cc5dd3,
title = "GLCCI1 rs37973 does not influence treatment response to inhaled corticosteroids in white subjects with asthma",
author = "Louise Hosking and Eugene Bleecker and Soumitra Ghosh and Astrid Yeo and Loretta Jacques and Michael Mosteller and Deborah Meyers",
note = "Funding Information: Disclosure of potential conflict of interest: L. Hosking, S. Ghosh, A. Yeo, L. Jacques, and M. Mosteller are employees of and hold stock in GlaxoSmithKline. E. Bleecker has received grants from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute, Aerovance, AstraZeneca, Boehringer-Ingelheim-Pfizer, Centocor, Cephalon, Ception, Forest, Genentech, GlaxoSmithKline, MedImmune, Novartis, and Sanofi-Aventis and has consultant arrangements with GlaxoSmithKline, Boehringer-Ingelheim-Pfizer, Forest, Novartis, Regeneron, and Sanofi-Aventis. D. Meyers has been supported by one or more grants from the NIH . The rest of the authors are employed by and own stock/stock options in GlaxoSmithKline. ",
year = "2014",
month = feb,
doi = "10.1016/j.jaci.2013.08.024",
language = "English (US)",
volume = "133",
pages = "587--589",
journal = "Journal of Allergy and Clinical Immunology",
issn = "0091-6749",
publisher = "Elsevier Inc.",
number = "2",
}